US Stock MarketDetailed Quotes

BNTC Benitec Biopharma

Watchlist
  • 8.9500
  • +0.0814+0.92%
Trading May 3 15:33 ET
23.20MMarket Cap-876P/E (TTM)

Benitec Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(Q3)Mar 31, 2023
(Q2)Dec 31, 2022
(Q1)Sep 30, 2022
(FY)Jun 30, 2022
(Q4)Jun 30, 2022
(Q3)Mar 31, 2022
Total revenue
0
0
2.74%75K
7K
12.50%54K
-44.00%14K
0
23.73%73K
0
4,700.00%48K
Operating revenue
--0
--0
2.74%75K
--7K
12.50%54K
-44.00%14K
--0
23.73%73K
--0
4,700.00%48K
Cost of revenue
1K
-106K
0
0
0
-92.68%9K
Gross profit
-107.14%-1K
106K
17.19%75K
14K
0
200.00%64K
Operating expense
23.15%6.93M
30.57%5.98M
6.91%19.16M
-3.64%4.56M
25.29%4.4M
15.72%5.62M
-5.02%4.58M
32.41%17.92M
22.64%4.73M
-7.37%3.51M
Selling and administrative expenses
-2.09%1.82M
-19.22%1.55M
-3.97%6.38M
-11.72%1.37M
-8.15%1.23M
8.69%1.86M
-5.97%1.92M
2.06%6.65M
1.11%1.55M
29.93%1.34M
-General and administrative expense
-2.09%1.82M
-19.22%1.55M
-3.97%6.38M
-11.72%1.37M
-8.15%1.23M
8.69%1.86M
-5.97%1.92M
2.06%6.65M
1.11%1.55M
29.93%1.34M
Research and development costs
35.66%5.1M
66.50%4.43M
13.33%12.77M
0.31%3.19M
45.88%3.17M
19.55%3.76M
-4.32%2.66M
60.57%11.27M
36.90%3.18M
-21.28%2.17M
Operating profit
-23.48%-6.93M
-28.25%-5.87M
-6.87%-19.08M
3.97%-4.55M
-25.46%-4.34M
-16.03%-5.61M
5.02%-4.58M
-31.32%-17.85M
-22.91%-4.74M
8.78%-3.46M
Net non-operating interest income expense
33.33%-6K
33.33%-6K
-3.13%-33K
20.00%-8K
30.00%-7K
18.18%-9K
-800.00%-9K
-433.33%-32K
-900.00%-10K
-400.00%-10K
Non-operating interest expense
-33.33%6K
-33.33%6K
3.13%33K
-20.00%8K
-30.00%7K
-18.18%9K
800.00%9K
433.33%32K
900.00%10K
400.00%10K
Other net income (expense)
-35.10%135K
85.32%-74K
-39.13%-448K
67.71%-103K
-125.13%-49K
732.00%208K
-127.03%-504K
-15.00%-322K
-117.01%-319K
271.05%195K
Gain on sale of security
-4.43%151K
88.89%-56K
-72.02%-418K
91.45%-23K
-121.88%-49K
532.00%158K
-127.03%-504K
23.34%-243K
-82.99%-269K
296.49%224K
Other non- operating income (expenses)
-132.00%-16K
---18K
62.03%-30K
-60.00%-80K
----
--50K
----
-313.51%-79K
---50K
---29K
Income before tax
-25.63%-6.8M
-16.91%-5.95M
-7.44%-19.56M
8.01%-4.66M
-34.26%-4.4M
-12.24%-5.41M
-0.95%-5.09M
-31.16%-18.21M
-26.58%-5.07M
16.22%-3.28M
Income tax
Net income
-25.63%-6.8M
-16.91%-5.95M
-7.44%-19.56M
8.01%-4.66M
-34.26%-4.4M
-12.24%-5.41M
-0.95%-5.09M
-31.16%-18.21M
-26.58%-5.07M
16.22%-3.28M
Net income continuous Operations
-25.63%-6.8M
-16.91%-5.95M
-7.44%-19.56M
8.01%-4.66M
-34.26%-4.4M
-12.24%-5.41M
-0.95%-5.09M
-31.16%-18.21M
-26.58%-5.07M
16.22%-3.28M
Minority interest income
Net income attributable to the parent company
-25.63%-6.8M
-16.91%-5.95M
-7.44%-19.56M
8.01%-4.66M
-34.26%-4.4M
-12.24%-5.41M
-0.95%-5.09M
-31.16%-18.21M
-26.58%-5.07M
16.22%-3.28M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-25.63%-6.8M
-16.91%-5.95M
-7.44%-19.56M
8.01%-4.66M
-34.26%-4.4M
-12.24%-5.41M
-0.95%-5.09M
-31.16%-18.21M
-26.58%-5.07M
16.22%-3.28M
Basic earnings per share
20.96%-2.64
65.41%-2.76
62.72%-240.04
73.14%-2.8318
60.00%-2.72
66.70%-3.34
24.29%-7.98
-1,072.76%-643.96
-26.58%-10.5412
51.22%-6.8
Diluted earnings per share
20.96%-2.64
65.41%-2.76
62.72%-240.04
73.14%-2.8318
60.00%-2.72
66.70%-3.34
24.29%-7.98
-1,072.76%-643.96
-26.58%-10.5412
51.22%-6.8
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q4)Jun 30, 2023(Q3)Mar 31, 2023(Q2)Dec 31, 2022(Q1)Sep 30, 2022(FY)Jun 30, 2022(Q4)Jun 30, 2022(Q3)Mar 31, 2022
Total revenue 002.74%75K7K12.50%54K-44.00%14K023.73%73K04,700.00%48K
Operating revenue --0--02.74%75K--7K12.50%54K-44.00%14K--023.73%73K--04,700.00%48K
Cost of revenue 1K-106K000-92.68%9K
Gross profit -107.14%-1K106K17.19%75K14K0200.00%64K
Operating expense 23.15%6.93M30.57%5.98M6.91%19.16M-3.64%4.56M25.29%4.4M15.72%5.62M-5.02%4.58M32.41%17.92M22.64%4.73M-7.37%3.51M
Selling and administrative expenses -2.09%1.82M-19.22%1.55M-3.97%6.38M-11.72%1.37M-8.15%1.23M8.69%1.86M-5.97%1.92M2.06%6.65M1.11%1.55M29.93%1.34M
-General and administrative expense -2.09%1.82M-19.22%1.55M-3.97%6.38M-11.72%1.37M-8.15%1.23M8.69%1.86M-5.97%1.92M2.06%6.65M1.11%1.55M29.93%1.34M
Research and development costs 35.66%5.1M66.50%4.43M13.33%12.77M0.31%3.19M45.88%3.17M19.55%3.76M-4.32%2.66M60.57%11.27M36.90%3.18M-21.28%2.17M
Operating profit -23.48%-6.93M-28.25%-5.87M-6.87%-19.08M3.97%-4.55M-25.46%-4.34M-16.03%-5.61M5.02%-4.58M-31.32%-17.85M-22.91%-4.74M8.78%-3.46M
Net non-operating interest income expense 33.33%-6K33.33%-6K-3.13%-33K20.00%-8K30.00%-7K18.18%-9K-800.00%-9K-433.33%-32K-900.00%-10K-400.00%-10K
Non-operating interest expense -33.33%6K-33.33%6K3.13%33K-20.00%8K-30.00%7K-18.18%9K800.00%9K433.33%32K900.00%10K400.00%10K
Other net income (expense) -35.10%135K85.32%-74K-39.13%-448K67.71%-103K-125.13%-49K732.00%208K-127.03%-504K-15.00%-322K-117.01%-319K271.05%195K
Gain on sale of security -4.43%151K88.89%-56K-72.02%-418K91.45%-23K-121.88%-49K532.00%158K-127.03%-504K23.34%-243K-82.99%-269K296.49%224K
Other non- operating income (expenses) -132.00%-16K---18K62.03%-30K-60.00%-80K------50K-----313.51%-79K---50K---29K
Income before tax -25.63%-6.8M-16.91%-5.95M-7.44%-19.56M8.01%-4.66M-34.26%-4.4M-12.24%-5.41M-0.95%-5.09M-31.16%-18.21M-26.58%-5.07M16.22%-3.28M
Income tax
Net income -25.63%-6.8M-16.91%-5.95M-7.44%-19.56M8.01%-4.66M-34.26%-4.4M-12.24%-5.41M-0.95%-5.09M-31.16%-18.21M-26.58%-5.07M16.22%-3.28M
Net income continuous Operations -25.63%-6.8M-16.91%-5.95M-7.44%-19.56M8.01%-4.66M-34.26%-4.4M-12.24%-5.41M-0.95%-5.09M-31.16%-18.21M-26.58%-5.07M16.22%-3.28M
Minority interest income
Net income attributable to the parent company -25.63%-6.8M-16.91%-5.95M-7.44%-19.56M8.01%-4.66M-34.26%-4.4M-12.24%-5.41M-0.95%-5.09M-31.16%-18.21M-26.58%-5.07M16.22%-3.28M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -25.63%-6.8M-16.91%-5.95M-7.44%-19.56M8.01%-4.66M-34.26%-4.4M-12.24%-5.41M-0.95%-5.09M-31.16%-18.21M-26.58%-5.07M16.22%-3.28M
Basic earnings per share 20.96%-2.6465.41%-2.7662.72%-240.0473.14%-2.831860.00%-2.7266.70%-3.3424.29%-7.98-1,072.76%-643.96-26.58%-10.541251.22%-6.8
Diluted earnings per share 20.96%-2.6465.41%-2.7662.72%-240.0473.14%-2.831860.00%-2.7266.70%-3.3424.29%-7.98-1,072.76%-643.96-26.58%-10.541251.22%-6.8
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Top Gainers Yesterday
Top Gainers Yesterday
Intraday+1.27%